Lawrence P. Guiheen - Mar 6, 2023 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Lawrence P. Guiheen, by Brian Lenz as Attorney-in-fact
Stock symbol
ADMA
Transactions as of
Mar 6, 2023
Transactions value $
$0
Form type
4
Date filed
3/8/2023, 08:30 PM
Previous filing
Mar 9, 2022
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Award $0 +25.8K +24.8% $0.00 130K Mar 6, 2023 Direct F1, F2
holding ADMA Common Stock 1K Mar 6, 2023 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Employee Stock Option (right to buy) Award $0 +51.6K $0.00 51.6K Mar 6, 2023 Common Stock 51.6K $3.35 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
F2 Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 90,793 shares of common stock owned by the reporting person.
F3 These shares are owned by the Guiheen Trust, of which Mr. Guiheen serves as a joint trustee.
F4 The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.